Biotechnology SHAREHOLDER ALERT: Monteverde & Associates Are Investigating the Following Merger October 1, 2020
Biotechnology Allogene Therapeutics Announces October 2020 Virtual Investor Conference Participation October 1, 2020
Biotechnology Arena Pharmaceuticals Completes Full Enrollment of Olorinab Phase 2 CAPTIVATE Trial for Abdominal Pain in Irritable Bowel Syndrome October 1, 2020
Biotechnology BMRN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 24, 2020 in the Class Action Filed on Behalf of BioMarin Pharmaceutical Inc. Limited Shareholders September 30, 2020
Biotechnology IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm September 30, 2020
Search
Biotechnology
